Table 1.
Characteristics of the patients with schizophrenia
| EGUIDE (+) | EGUIDE (−) | |
|---|---|---|
| Number of patients | n = 2106 | n = 5299 |
| Age, mean (SD) years | 45.6 (15.4) | 46.2 (15.7) |
| Sex, No. (%) | ||
| Male | 943 (44.8) | 2408 (45.4) |
| Female | 1163 (55.2) | 2891 (54.6) |
| Institution, No. (%) | ||
| University hospitals | 863 (41.0) | 1757 (33.2) |
| Public hospitals | 663 (31.5) | 2131 (40.2) |
| Private hospitals | 580 (27.5) | 1411 (26.6) |
| QIs, No. (%) | ||
| SQI‐1: Antipsychotic monotherapy | 1234 (58.6) | 2849 (53.8) |
| SQI‐2: Antipsychotic monotherapy without other psychotropics | 438 (20.8) | 828 (15.6) |
| SQI‐3: No prescription of anxiolytics or hypnotics | 793 (37.7) | 1749 (33.0) |
| SQI‐4: No prescription of antidepressants | 1929 (91.6) | 4814 (90.8) |
| SQI‐5: No prescription of mood stabilizers or antiepileptics | 1597 (75.8) | 3912 (73.8) |
| SQI‐6: Use of long‐acting injectable antipsychotic | 222 (10.5) | 481 (9.1) |
| SQI‐7: Clozapine treatment | 116 (5.5) | 313 (5.9) |
| SQI‐8: Modified electroconvulsive therapy (mECT) | 110 (5.2) | 306 (5.8) |
EGUIDE (+), patients treated by psychiatrists who participated in the EGUIDE project; EGUIDE (−), patients treated by psychiatrists who did not participate in the EGUIDE project; SD, standard deviation; SQI, quality indicator of schizophrenia.